Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

HEMACARE EXTENDS WARRANT EXPIRATION

Sep. 27, 1991

MGI GETS RIGHTS TO PILOCARPINE MOUTHWASH

Sep. 27, 1991

EPITOPE GETS GRANT FOR HIV TEST

Sep. 27, 1991

UCLA TESTS TIL CELLS ON KIDNEY CANCER

Sep. 26, 1991

USDA APPROVES SYNTRO VACCINE

Sep. 26, 1991

BOEHRINGER TO BUY 19.9% OF BIOWHITTAKER

Sep. 26, 1991

QUIDEL TO MARKET TEST FOR H. PYLORI

Sep. 26, 1991

PROCYTE TESTS AGAINST BOWEL DISEASE

Sep. 26, 1991

LOWER-THAN-EXPECTED INCSTAR EARNINGS

Sep. 26, 1991

PTO MAY NOT ISSUE GM-CSF PATENT

Sep. 26, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...